Search

everythinglearnresearchcommunity

for

Search:↓

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

New acne treatments show promise as alternatives to traditional therapies.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Hairless mammals have genetic changes in both their protein-coding and regulatory sequences related to hair.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

People with alopecia have a higher risk of thyroid cancer.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

PRP treatment may help with alopecia areata, especially in newer cases.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Topical tofacitinib is effective and safe for treating alopecia areata.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.